Case report: Insulin-like growth factor II expression in hepatocellular carcinoma with alcoholic liver fibrosis accompanied by hypoglycaemia

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 1, 1998, Pages 47-51

  Yamaguchi, Masako ^a   Kamimura, Seiichiro ^a   Takada, Junichi ^a   Iwata, Kaoru ^a   Iida, Takeshi ^a   Kobayashi, Kazuo ^a   Nakano, Hajime ^a   Okada, Yasuhiro ^a   Fujiimi, Satoru ^a   Sohda, Tetsuro ^b   Hizuka, Naomi ^c  

^a FUKUOKA RED CROSS HOSPITAL   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Alcoholic liver fibrosis; Hepatocellular carcinoma; Hypoglycaemia; Immunohistochemistry; Insulin like growth factor II

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; GLUCOSE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; LIVER CELL CARCINOMA; LIVER FIBROSIS; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 14444267347     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00544.x     Document Type: Article

References (22)

1. Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors. Annu. Rev. Physiol. 1985; 47: 443-67.
2. Brown AL, Graham DE, Nissley SP, Hill DJ, Strain AJ, Rechler MM. Developmental regulation of insulin-like growth factor II mRNA in different rat tissues. J. Biol. Chem. 1986; 261: 13 144-50.
3. Humbel RE. Insulin-like growth factor I and II. Eur. J. Biochem. 1990; 190: 445-62.
4. Moses AC, Nissley SP, Short PA et al. Increased levels of multiplication stimulation activity, an insulin-like growth factor, in fetal rat serum. Proc. Natl Acad. Sci. USA 1980; 77: 3649-53.
5. LeRoith D, Baserga R, Helman L, Roberts CT Jr. Insulin-like growth factors and cancer. Ann. Intern. Med. 1995; 122: 54-9.
6. Megyesi K, Kahn CR, Roth J, Gorden P. Hypoglycemia in association with extrapancreatic tumors. Demonstration of elevated plasma NSILA-s by a new radio-receptor assay. J. Clin. Endocrinol. Mctab. 1974; 38: 931-4.
7. Gorden P, Hendricks CM, Kahn CR, Megyesi K, Roth J. Hypoglycemia associated with non-islet-cell tumor and insulin like growth factors. N. Engl. J. Med. 1981; 305: 1452-5.
8. Daughaday WH, Trivedi B. Measurement of derivatives of proinsulin-like growth factor II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J. Clin. Endocrinol. Metab. 1992; 75: 110-15.
9. Lamas E, LeBail B, Housset C, Boucher O, Bréchot C. Localization of insulin-like growth factor-II and hepatitis B virus mRNAs and proteins in human hepatocellular carcinomas. Lab. Invest. 1991; 64: 98-104.
10. Sohda T, Kamimura S, Iwata K, Shijo H, Okumura M. Immunohistological evidence of insulin-like growth factor II in human small hepatocellular carcinoma with hepatitis C virus infection: Relationship to fatty change in carcinoma cells. J. Gastroenterol. Hepatol. 1997; 12: 224-8.
11. Yonei Y, Tanaka M, Ozawa Y et al. Primary hepatocellular carcinoma with severe hypoglycemia: Involvement of insulin-like growth factors. Liver 1992; 12: 90-3.
12. Takase S, Tsutsumi M, Kawahara H, Takada N, Takada A. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology 1993; 17: 9-13.
13. Sohda T, Yun K, Iwata K, Soejima H, Okumura M. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level. Lab. Invest. 1996; 75: 307-11.
14. Fukuda I, Hizuka N, Takano K, Asakawa-Yasumoto K, Shimizu K, Demura H. Characterization of insulin-like growth factor II (IGF-II) and IGF binding proteins in patients with non-islet-cell tumor hypoglycemia. Endocrine J. 1993; 40: 111-19.
15. Nadler WH, Wolfer JA. Hepatogenic hypoglycemia associated with primary liver cell carcinoma. Arch. Intern. Med. 1929; 44: 700-10.
16. McFadzean AJ, Yeung RT. Futher observations on hypoglycemia in hepatocellular carcinoma. Am. J. Med. 1969; 47: 220-35.
17. Su Q, Liu Y-F, Zhang J-F, Zhang S-X, Li D-F, Yang J-J. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: Its relationship with hepatitis B virus antigen expression. Hepatology 1994; 19: 788-99.
18. Zapf J, Schmid C, Guler HP et al. Regulation of binding proteins for insulin-like growth factors (IGF) in humans: Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J. Clin. Invest. 1990; 86: 952-61.
19. Cotterill AM, Holly JM, Davies SC, Coulson VJ, Price PA, Wass JA. The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumor-associated hypoglycemia. J. Endocrinol. 1991; 131: 303-11.
20. Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC, Tager HS. Tumor hypoglycemia: Relationship to high molecular weight insulin-like growth factor-II. J. Clin. Invest. 1990; 85: 1672-9.
21. D'Arville CN, Nouri-Aria KT, Johnson P, Williams R. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma. Hepatology 1991; 13: 310-15.
22. Sohda T, Oka Y, Iwata K et al. Co-localisation of insulin-like growth factor II and the proliferation marker MIB-I in hepatocellular carcinoma cells. J. Clin. Pathol. 1997; 50: 135-7.